RAPT Therapeutics (RAPT) Profit After Tax: 2020-2023
Historic Profit After Tax for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to -$30.9 million.
- Therapeutics' Profit After Tax fell 34.54% to -$30.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$116.8 million, marking a year-over-year decrease of 39.32%. This contributed to the annual value of -$116.8 million for FY2023, which is 39.32% down from last year.
- Latest data reveals that Therapeutics reported Profit After Tax of -$30.9 million as of Q4 2023, which was up 1.57% from -$31.4 million recorded in Q3 2023.
- In the past 5 years, Therapeutics' Profit After Tax registered a high of -$12.4 million during Q2 2020, and its lowest value of -$31.4 million during Q3 2023.
- Over the past 3 years, Therapeutics' median Profit After Tax value was -$20.9 million (recorded in 2022), while the average stood at -$22.5 million.
- Data for Therapeutics' Profit After Tax shows a maximum YoY crashed of 47.73% (in 2023) over the last 5 years.
- Over the past 4 years, Therapeutics' Profit After Tax (Quarterly) stood at -$12.7 million in 2020, then crashed by 40.79% to -$17.9 million in 2021, then declined by 28.01% to -$23.0 million in 2022, then slumped by 34.54% to -$30.9 million in 2023.
- Its Profit After Tax stands at -$30.9 million for Q4 2023, versus -$31.4 million for Q3 2023 and -$25.3 million for Q2 2023.